NVTIA supports qualified ingredient, documentation, intellectual-property and product-development inquiries with a clear focus on identity, specifications and market-appropriate evidence.
Capabilities, responsible parties, documentation availability, timelines and regulatory status are confirmed for each qualified inquiry.
Technology, owner, publication number, jurisdiction and status are reviewed before licensing discussions.
Identity, specification, documentation, availability, MOQ and supply terms are confirmed by project.
Defined botanical materials, target markers and specification requirements guide technical discussions.
Formulation and manufacturing coordination is subject to confirmed partner capabilities and written scope.
Available literature and product-specific evidence requirements are reviewed without overstating conclusions.
Market-specific information mapping is supported; timelines and regulatory outcomes are not guaranteed.
Strong ingredient work begins with the exact botanical source, preparation, marker compounds, intended use and target market. NVTIA structures qualified discussions around those details.
NVTIA works with Professor Gregg L. Semenza, 2019 Nobel Laureate in Physiology or Medicine and member of the U.S. National Academy of Sciences, in scientific and academic exchange concerning cellular oxygen biology.
This collaboration informs scientific discussion and research questions. It does not by itself establish the efficacy, safety or regulatory status of a specific commercial ingredient or finished product.
Photographs shown here are from NVTIA academic exchange activities and are used with authorization.
No single certification or regulatory status applies automatically to every ingredient. Available specifications, analytical data, certifications and market status must be confirmed for the exact material and intended use.
Supplied USPTO assignment records identify Nutricare Solutions Inc., a New York corporation, as the recorded assignee as of the latest supplied recordation.